Clinical Trials Logo

Left Bundle-Branch Block clinical trials

View clinical trials related to Left Bundle-Branch Block.

Filter by:

NCT ID: NCT04416958 Recruiting - ICD Clinical Trials

Pacing to Maintain Physiologic Ventricular Activation

Pace-Conduct
Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

Right ventricular pacing causes ventricular dyssynchrony and may be associated with impaired outcome. In the last decade, several approaches for more physiological pacing became available and were implemented in the latest guidelines. However, compared to conventional device implantation, cardiac resynchronization, His bundle pacing and left bundle area pacing remain demanding procedures in the individual case. Goal of the single center observational "Pace conduct" study is to evaluate implantation success, safety and outcome of pacing methods that maintain physiologic ventricular activation.

NCT ID: NCT04409119 Recruiting - Heart Failure Clinical Trials

Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.

HIS-alt_2
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The study will investigate the feasibility of using direct HIS pacing or left bundle branch pacing (LBB pacing) as an alternative to biventricular pacing in patients with symptomatic heart failure and an ECG with a typical left bundle branch block pattern.

NCT ID: NCT04293471 Recruiting - Clinical trials for Left Bundle-Branch Block

Prediction of Outcome by Echocardiography in Left Bundle Branch Block

EchoLBBB
Start date: April 15, 2021
Phase:
Study type: Observational [Patient Registry]

Patients with left bundle branch block have an increased risk for the development of heart-failure and death. However, risk factors for unfavorable outcomes are still poorly defined. This study aims to identify echocardiographic parameters and ECG characteristics by machine learning in order to develop individual risk assessment

NCT ID: NCT04128384 Recruiting - Clinical trials for Left Bundle-Branch Block

Infranodal Conduction Time During TAVR as Predictor of HAVB

HOM-TAVI
Start date: June 21, 2018
Phase: N/A
Study type: Interventional

Consecutive patients with high grade aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) with a self-expanding valve (Medtronic CoreValve Evolut R® or Edwards Sapien S3®) without pre-existing pacemaker devices are eligible for inclusion. During the TAVR procedure, an electrophysiologic study including measurements of infranodal conduction times (HV-interval before and after valve implantation) will be performed. Electrocardiograms before TAVR, before discharge, after 30 days and after 12 months will be analyzed regarding new onset LBB and the occurrence of high-degree AV block (HAVB) .

NCT ID: NCT03415945 Recruiting - Heart Failure Clinical Trials

Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy

Start date: November 23, 2017
Phase: N/A
Study type: Interventional

In cardiac resynchronization therapy (CRT), biventricular pacing is performed by pacing the right ventricle (RV) and epicardium of the left ventricular (LV) postero-lateral wall. A significant proportion of apparently suitable patients fail to benefit from CRT. One of the problems of CRT is proper positioning and fixation of the LV pacing lead in the coronary vein. LV septal pacing may be a good alternative for BiV pacing in patients with an indication for CRT.

NCT ID: NCT03303612 Recruiting - Clinical trials for Aortic Valve Stenosis

Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

COME-TAVI
Start date: October 15, 2017
Phase: N/A
Study type: Interventional

The primary hypothesis of the proposed study is that an electrophysiology-based algorithmic approach is superior to standard clinical follow-up with 30-day monitoring in reducing the combined endpoint of syncope, hospitalization, and death in patients in patients with new of left bundle branch block following transcatheter aortic valve implantation (TAVI).

NCT ID: NCT02659137 Recruiting - Clinical trials for Transcatheter Aortic Valve Replacement

HV Electrophysiology Study In Transcatheter Aortic Valve Implantation Patients

HESITATE
Start date: January 2016
Phase: N/A
Study type: Observational

TAVI induced LBBB is a complication that occurs between 7 and 65 % of the cases, numbers that differ considerably between devices. There is an increased risk of progression to total AV‐block at follow‐up, with the risk of brady‐arrhythmic death. The aim of the study is to elucidate the anatomical location of the conduction pathology of a TAVI induced LBBB. This could impact valve design and placement and thereby reduce the number of new LBBB induced by TAVI in the future. Furthermore, finding predictors for progression to a high degree AV block in the follow‐up (and thus an indication for permanent pacemaker) could improve management of post‐operative conduction abnormalities and prevent the risk of brady‐arrhythmic death.

NCT ID: NCT01415024 Recruiting - Heart Failure Clinical Trials

Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication

CRTICD Dual LV
Start date: May 2011
Phase: Phase 4
Study type: Interventional

Today patients with a Cardiac Resynchronization Therapy (CRT) indication usually receive 2 ventricular leads, right ventricular (RV) apex and left ventricular (LV) (postero-) lateral, gaining a responder rate of approximately 70%. However, the physiological agitation of the left ventricle takes place over two pathways. Therefore single point stimulation might be insufficient for a dilated, insufficiently and asynchronously contracting left ventricle, resulting in either insufficient or no response to the therapy. In the "CRT ICD Dual LV" study the patients receive a second LV lead in an anterior vein. When this lead is placed, temporary dual LV stimulation is started. To assess the effectivity of the dual LV lead stimulation intraoperatively a LV dp/dt-pressure measurement is taken. If there is an increase in LV dp/dt, the patients will be stimulated with both leads permanently. If not they will be stimulated conventionally. The patients participating in this study are monitored for 12 months after implantation.